glp-1 and cancer risk Could medications help slow progression?⁣ ⁣ A new Cleveland Clinic study found those taking GLP-1s were less likely to develop stage IV disease in several cancer types, when compared to GLP-1s tied to lower risk

No adequate clinical evidence establishes Melanotan I as a skin-cancer prevention treatment

There is the striking case of a 68-year-old Japanese man whose hair was practically all white, but following the administration of a therapeutic antibody for persistent inflammation of the skin, half of his hair reverted back to its natural black colour

There are ways our bodies can combat free radicals

Structurally identical to the biologically active 129 N-terminal amino acids of native GHRH, Sermorelin preserves full receptor agonist activity

During the eligibility screening, articles that met the following criteria were included in the review: (1) has been peer reviewed

doi:10.1097/icu.0b013e3283622718